Technical Analysis for MIST - Milestone Pharmaceuticals Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 1.49 | 2.76% | 0.04 |
MIST closed up 2.76 percent on Monday, March 18, 2024, on 79 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 27
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Buy Signal | Bullish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Inside Day | Range Contraction | 2.76% | |
Wide Bands | Range Expansion | 2.76% | |
Oversold Stochastic | Weakness | 2.76% | |
Wide Bands | Range Expansion | 4.93% | |
Down 3 Days in a Row | Weakness | 4.93% | |
Oversold Stochastic | Weakness | 4.93% | |
NR7 | Range Contraction | 2.76% |
Alert | Time |
---|---|
10 DMA Resistance | about 14 hours ago |
Up 3% | about 14 hours ago |
60 Minute Opening Range Breakout | about 15 hours ago |
Rose Above Previous Day's High | about 15 hours ago |
Up 2% | about 15 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/27/2024
Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes drugs for the treatment of cardiovascular indications. It offers Etripamil that completed Phase 2 clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for treating Atrial Fibrillation and Angina. The company was founded in 2003 and is headquartered in Montréal, Canada.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cardiology Cardiac Arrhythmia Atrial Fibrillation Angina Cardiovascular System Circulatory System Tachycardia Ventricular Tachycardia
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cardiology Cardiac Arrhythmia Atrial Fibrillation Angina Cardiovascular System Circulatory System Tachycardia Ventricular Tachycardia
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.48 |
52 Week Low | 1.35 |
Average Volume | 369,579 |
200-Day Moving Average | 2.63 |
50-Day Moving Average | 1.61 |
20-Day Moving Average | 1.63 |
10-Day Moving Average | 1.49 |
Average True Range | 0.16 |
RSI (14) | 44.44 |
ADX | 16.43 |
+DI | 18.25 |
-DI | 20.50 |
Chandelier Exit (Long, 3 ATRs) | 1.93 |
Chandelier Exit (Short, 3 ATRs) | 1.83 |
Upper Bollinger Bands | 2.09 |
Lower Bollinger Band | 1.17 |
Percent B (%b) | 0.35 |
BandWidth | 56.64 |
MACD Line | -0.07 |
MACD Signal Line | -0.05 |
MACD Histogram | -0.0167 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.68 | ||||
Resistance 3 (R3) | 1.67 | 1.59 | 1.65 | ||
Resistance 2 (R2) | 1.59 | 1.54 | 1.60 | 1.64 | |
Resistance 1 (R1) | 1.54 | 1.51 | 1.57 | 1.55 | 1.63 |
Pivot Point | 1.47 | 1.47 | 1.48 | 1.47 | 1.47 |
Support 1 (S1) | 1.42 | 1.42 | 1.44 | 1.43 | 1.35 |
Support 2 (S2) | 1.34 | 1.39 | 1.35 | 1.34 | |
Support 3 (S3) | 1.29 | 1.34 | 1.33 | ||
Support 4 (S4) | 1.30 |